Ligand Pharmaceuticals Inc (LGND, LGNDZ, LGNXZ, LGNYZ, LGNZZ)

CIK 886163 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ligand Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Nov 4, 20261440001957799-26-000193
Nov 4, 202640001950232-26-000006
Nov 3, 202640001376960-26-000005
Nov 3, 2026SCHEDULE 13D/A0001193125-26-445875
Nov 2, 20261440001957799-26-000192
Oct 30, 202610-Q0000886163-26-000060
Oct 30, 20261440001950047-26-010515
Oct 30, 20261440001949846-26-000627
Oct 29, 20268-K0000886163-26-000058
Oct 6, 202640001950232-26-000003
Sep 24, 20268-K0000886163-26-000054
Sep 24, 202640002001011-26-000142
Sep 22, 20268-K0000886163-26-000050
Sep 14, 202640002001011-26-000140
Sep 10, 20261440001950047-26-009263
Sep 8, 202640002001011-26-000137
Sep 3, 20261440001950047-26-009091
Sep 2, 20268-K/A0000886163-26-000048
Aug 14, 202640002001011-26-000115
Aug 14, 202640002001011-26-000114
Aug 13, 2026SCHEDULE 13G0000914208-26-000299
Aug 12, 20261440001950047-26-008026
Aug 12, 20261440001950047-26-008011
Aug 7, 202610-Q0000886163-26-000044
Aug 6, 20268-K0000886163-26-000041